As health care costs spiral higher, hospital price increases are flying under the radar
Worse quality of life for many despite ‘miracle’ TAVR heart procedure
Why biotech celeb Craig Venter’s prostate cancer story should be read with healthy dose of skepticism
Too many stories ignore or under-report the harms of cancer immunotherapies. Here’s what the public needs to know.
Journalists need to prune the overgrowth in the jungle of supplement news
What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups
Despite thumbs down from professional groups, mass prostate cancer screening events continue, often with misleading promotions
As radiologists push for “virtual” colonoscopy coverage, risk of misleading readers is real
Seven intriguing angles on the EpiPen price-gouging story
Where are the TV ads to “educate” patients about the negative Opdivo lung cancer trial?